New wound dressings to speed up healing for diabetic patients
Regenerative wound dressings for accelerating diabetic wound healing
This study is testing a new type of wound dressing for people with diabetes that helps speed up healing by reducing inflammation and helping healing cells get to the wound more effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10885066 on NIH RePORTER |
What this research studies
This research focuses on developing innovative wound dressings specifically designed to accelerate the healing of chronic wounds in diabetic patients. The approach involves creating a peptide-based inhibitor that targets specific pathways involved in inflammation and cell migration, combined with a hydrogel that scavenges reactive oxygen species. By continuously releasing the inhibitor, the dressing aims to improve the healing process by reducing inflammation and enhancing the movement of healing cells to the wound site. This could potentially lead to faster recovery times and better outcomes for patients with diabetic wounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are experiencing chronic wounds that are slow to heal.
Not a fit: Patients with acute wounds or those without diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve healing times for diabetic patients suffering from chronic wounds, potentially reducing the risk of amputation.
How similar studies have performed: While there have been various approaches to diabetic wound healing, this specific method of using a dual-action wound dressing is novel and has not been extensively tested in prior research.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Guan, Jianjun — Washington University
- Study coordinator: Guan, Jianjun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.